AMN vs. CGON, PRVA, MRVI, GH, STAA, DYN, GERN, APGE, RXST, and NTLA
Should you be buying AMN Healthcare Services stock or one of its competitors? The main competitors of AMN Healthcare Services include CG Oncology (CGON), Privia Health Group (PRVA), Maravai LifeSciences (MRVI), Guardant Health (GH), STAAR Surgical (STAA), Dyne Therapeutics (DYN), Geron (GERN), Apogee Therapeutics (APGE), RxSight (RXST), and Intellia Therapeutics (NTLA). These companies are all part of the "medical" sector.
CG Oncology (NASDAQ:CGON) and AMN Healthcare Services (NYSE:AMN) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation, earnings and community ranking.
26.6% of CG Oncology shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 0.9% of AMN Healthcare Services shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
AMN Healthcare Services has higher revenue and earnings than CG Oncology.
CG Oncology presently has a consensus target price of $63.75, suggesting a potential upside of 112.64%. AMN Healthcare Services has a consensus target price of $75.57, suggesting a potential upside of 28.79%. Given AMN Healthcare Services' stronger consensus rating and higher probable upside, equities research analysts plainly believe CG Oncology is more favorable than AMN Healthcare Services.
AMN Healthcare Services has a net margin of 4.13% compared to AMN Healthcare Services' net margin of 0.00%. CG Oncology's return on equity of 31.39% beat AMN Healthcare Services' return on equity.
AMN Healthcare Services received 430 more outperform votes than CG Oncology when rated by MarketBeat users. However, 80.00% of users gave CG Oncology an outperform vote while only 68.98% of users gave AMN Healthcare Services an outperform vote.
In the previous week, AMN Healthcare Services had 3 more articles in the media than CG Oncology. MarketBeat recorded 11 mentions for AMN Healthcare Services and 8 mentions for CG Oncology. CG Oncology's average media sentiment score of 0.46 beat AMN Healthcare Services' score of 0.33 indicating that AMN Healthcare Services is being referred to more favorably in the news media.
Summary
AMN Healthcare Services beats CG Oncology on 10 of the 14 factors compared between the two stocks.
Get AMN Healthcare Services News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AMN Healthcare Services Competitors List
Related Companies and Tools
